Back to Journals » Drug Design, Development and Therapy » Volume 12

Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer

Total article views   Abstract views HTML views PDF downloads Totals
14,206 Dovepress* 7,071 2,986+ 1,233 10,057
PubMed Central* 0 4,149 784 4,149
Totals 7,071 7,135 2,017 14,206
*Since 16 February 2018
+Since July 2016

View citations on PubMed Central and Google Scholar